Search Results - "Kim, Hongsik"

Role and future development of the KMA Policy by Kim, Hongsik

Get full text

HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer by Kim, Hongsik, Kim, Ryul, Kim, Hye Ryeon, Jo, Hyunji, Kim, Hana, Ha, Sang Yun, Park, Joon Oh, Park, Young Suk, Kim, Seung Tae

“…HER2 aberrations have been reported as a novel biomarker in HER2-directed therapy or as a prognostic marker in various tumor types. However, in advanced…”
Get full text

Novel diagnostic biomarkers for pancreatic cancer: assessing methylation status with epigenetic-specific peptide nucleic acid and KRAS mutation in cell-free DNA by Kim, Hongsik, Chu, Jinah, Do, In-Gu, Lee, Yong-Pyo, Kim, Hee Kyung, Yang, Yaewon, Kwon, Jihyun, Lee, Ki Hyeong, Batochir, Chinbayar, Jo, Eunji, Kim, Kyo Rim, Han, Hye Sook

“…Pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumor with a poor prognosis that poses challenges for diagnosis using traditional tissue-based…”
Get full text

A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer by Byeon, Seonggyu, Kim, Hongsik, Jeon, Hwang Gyun, Seo, Seong Il, Jeon, Seong Soo, Lee, Hyun Moo, Lee, Soon Il, Park, Se Hoon

“…The aim of this prospective phase II study was to evaluate the efficacy and safety of biweekly docetaxel plus androgen-deprivation therapy (ADT) in patients…”
Get full text

A Selected Review of Impacts of Ocean Deoxygenation on Fish and Fisheries by Kim, Hongsik, Franco, Ana C., Sumaila, U. Rashid

“…Oxygen is crucial for the survival of marine species. Yet, the ocean has experienced a loss of approximately 2% of its oxygen inventory since the last century,…”
Get full text

Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer by Kim, Hongsik, Kim, Hana, Kim, Ryul, Jo, Hyunji, Kim, Hye Ryeon, Hong, Joohyun, Park, Joon Oh, Park, Young Suk, Kim, Seung Tae

“…Background: High tumor mutational burden (TMB-H) has been reported as a predictive marker to immunotherapy or prognostic marker in various tumor types…”
Get full text

Efficacy of ferric carboxymaltose or darbepoetin alfa for chemotherapy-induced anemia in patients with esophagogastric or pancreaticobiliary cancer: a retrospective comparative study by Cho, Minkwan, Park, Eunkyung, Lee, Yong-Pyo, Kim, Hongsik, Park, Hee Sue, Kim, Hee Kyung, Yang, Yaewon, Kwon, Jihyun, Hyeong Lee, Ki, Han, Hye Sook

“…Esophagogastric and pancreaticobiliary cancers are associated with chronic blood loss, poor nutrition, and surgical interventions that interfere with iron…”
Get full text

The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers by Kim, Hye Ryeon, Ahn, Soomin, Jo, Hyunji, Kim, Hongsik, Hong, Joohyun, Lee, Jeeyun, Lim, Ho-Yeong, Kang, Won Ki, Kim, Seung Tae

“…Trastuzumab is a HER2-trargeted humanized monoclonal antibody that has been studied as a first-line treatment for patients with HER2-positive advanced gastric…”
Get full text

Discordance in HER2 status between primary gastric adenocarcinoma tumors and cells from the corresponding malignant effusions by Kim, Hongsik, Son, Seung-Myoung, Woo, Chang Gok, Lee, Ok-Jun, Kim, Dae Hoon, Yun, Hyo Yung, Yun, Jieun, Kim, Hee Kyung, Yang, Yaewon, Han, Hye Sook

“…Metastasis of gastric cancer commonly manifests as a malignant effusion, which presents an alternative cell source for human epidermal growth factor receptor 2…”
Get full text

Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer by Kim, Hongsik, Kim, Ryul, Jo, Hyunji, Kim, Hye Ryeon, Hong, Joohyun, Ha, Sang Yun, Park, Joon Oh, Kim, Seung Tae

“…Background: Expression of programmed death-ligand 1 (PD-L1) has been reported to correlate with response to immune checkpoint inhibitors (ICIs) in various…”
Get full text

Accelerating linked-list traversal through near-data processing by Byungchul Hong, Gwangsun Kim, Jung Ho Ahn, Yongkee Kwon, Hongsik Kim, Kim, John

“…Recent technology advances in memory system design, along with 3D stacking, have made near-data processing (NDP) more feasible to accelerate different…”
Get full text

Q-DRAM: Quick-Access DRAM with Decoupled Restoring from Row-Activation by Shin, Wongyu, Choi, Jungwhan, Jang, Jaemin, Suh, Jinwoong, Kwon, Yongkee, Moon, Youngsuk, Kim, Hongsik, Kim, Lee-Sup

“…The relatively high latency of DRAM is mostly caused by the long row-activation time which in fact consists of sensing and restoring time. Memory controllers…”
Get full text

A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma by Jo, Hyunji, Hong, Joohyun, Kim, Hongsik, Kim, Hye Ryeon, Kwon, Ghee Young, Kang, Kyung A, Park, Sung Yoon, Kim, Chan Kyo, Park, Byung Kwan, Chung, Jae Hoon, Song, Wan, Kang, Minyong, Sung, Hyun Hwan, Jeon, Hwang Gyun, Jeong, Byong Chang, Seo, Seong Il, Jeon, Seong Soo, Lee, Hyun Moo, Park, Se Hoon

“…Patients with International Metastatic RCC Database Consortium (IMDC) poor risk metastatic renal cell carcinoma (mRCC) rarely respond to first-line tyrosine…”
Get full text

Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries by Lee, Choong-kun, Yoo, Changhoon, Hong, Jung Yong, Park, Se Jun, Kim, Jin Won, Tai, David Wai Meng, Kim, Hyeyeong, Korphaisarn, Krittiya, Tanasanvimon, Suebpong, Chen, San-Chi, Kim, Ju Won, Kim, Ilhwan, Kim, Moonho, Choo, Joan, Oh, Sang-Bo, Chen, Ching-Tso, Bae, Woo Kyun, Kim, Hongsik, Huh, Seok Jae, Yen, Chia-Jui, Park, Sejung, Lee, Dong Ki, Chan, Landon Long, Kang, Beodeul, Kang, Minsu, Sundar, Raghav, Choi, Hye Jin, Chan, Stephen Lam, Chon, Hong Jae, Lee, Myung-Ah

“…Introduction: Atezolizumab plus bevacizumab is a commonly used first-line regimen for advanced hepatocellular carcinoma (HCC) treatment owing to its superior…”
Get full text

Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18 by Choi, Dae-Ho, Kim, Miso, Kim, Young Saing, Park, Keon Uk, Cho, Jang Ho, Kim, Hongsik, Lee, Ki Hyeong, Ahn, Heejoon, Kim, Il-Hwan, Lee, Kyung-Hee, Lee, Gyeong-Won, Yi, Seong Yoon, Ahn, Beung chul, Lee, Min-Young, Jung, Hyun Ae, Park, Sehhoon, Sun, Jong-Mu, Ahn, Jin Seok, Lee, Se-Hoon, Ahn, Myung-Ju

“…The role of maintenance durvalumab after definitive concurrent chemoradiotherapy (CCRT) in unresectable locally advanced NSCLC with EGFR mutation or ALK…”
Get full text

Triazoliptycenes: A Twist on Iptycene Chemistry for Regioselective Cross-Coupling To Build Nonstacking Fluorophores by Kang, Taewon, Kim, Hongsik, Lee, Dongwhan

“…Triazoliptycene fluorophores have been designed and synthesized, in which a three-dimensional propeller-like iptycene motif is employed to suppress…”
Get full text

Click-To-Twist Strategy To Build Blue-to-Green Emitters: Bulky Triazoles for Electronically Tunable and Thermally Activated Delayed Fluorescence by Kim, Hongsik, Lee, Youngnam, Lee, Hyeonho, Hong, Jong-In, Lee, Dongwhan

“…Discovery of a new chemical moiety is the foundation to build new functional materials. For charge-transfer-type thermally activated delayed fluorescence…”
Get full text

Powerful Direct C–H Amidation Polymerization Affords Single-Fluorophore-Based White-Light-Emitting Polysulfonamides by Fine-Tuning Hydrogen Bonds by Hwang, Soon-Hyeok, Kim, Hongsik, Ryu, Hanseul, Serdiuk, Illia E, Lee, Dongwhan, Choi, Tae-Lim

“…The development of white-light-emitting polymers has been actively pursued because of the importance of such polymers in various applications, such as lighting…”
Get full text

Cover by Yoo, Hyunjong, Kim, Hongsik, Min, Se Dong, Lee, Onseok

Get full text

Non-stackable molecules assemble into porous crystals displaying concerted cavity-changing motions by Kang, Taewon, Kim, Hongsik, Jeoung, Sungeun, Moon, Dohyun, Moon, Hoi Ri, Lee, Dongwhan

“…With small molecules, it is not easy to create large void spaces. Flat aromatics stack tightly, while flexible chains fold to fill the cavities. As an…”
Get full text